Trial Profile
A Study on the efficacy and safety of Docetaxel plus Nedaplatin in patients with advanced non-small-cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Nedaplatin (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 09 Feb 2011 New trial record